Treatment of NOD Diabetes with a Novel Peptide of the hsp60 Molecule Induces Th2-type Antibodies

By Bockova J.   Elias D.   Cohen I.R.  

Journal of Autoimmunity, Vol. 10, Iss. 4, 1997-08 ,pp. : 323-329

Academic Press

Access to resources Recommend Favorite

NOD Mouse Diabetes: The Ubiquitous Mouse Hsp60 is a beta-Cell Target Antigen of Autoimmune T Cells

By Birk O.S.   Elias D.   Weiss A.S.   Rosen A.   van-der Zee R.   Walker M.D.   Cohen I.R.  

Journal of Autoimmunity, Vol. 9, Iss. 2, 1996-02 ,pp. : 159-166

Academic Press

Access to resources Recommend Favorite

The Th1/Th2 Dichotomy, hsp60 Autoimmunity, and Type I Diabetes

By Cohen I.R.  

Clinical Immunology, Vol. 84, Iss. 2, 1997-08 ,pp. : 103-106

Academic Press

Access to resources Recommend Favorite

Oral Administration of the Immunodominant B-chain of Insulin Reduces Diabetes in a Co-transfer Model of Diabetes in the NOD Mouse and is Associated with a Switch from Th1 to Th2 Cytokines

By Polanski M.   Melican N.S.   Zhang J.   Weiner H.L.  

Journal of Autoimmunity, Vol. 10, Iss. 4, 1997-08 ,pp. : 339-346

Academic Press

Access to resources Recommend Favorite

Prevention of Diabetes Recurrence After Syngeneic Islet Transplantation in NOD Mice by Analogues of 1,25(OH) 2 D 3 in Combination With Cyclosporin A: Mechanism of Action Involves an Immune Shift From TH1 to TH2

By Mathieu C.   Casteels K.   Waer M.   Laureys J.   Valckx D.   Bouillon R.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 541-541

Elsevier

Access to resources Recommend Favorite